Literature DB >> 7851452

Sleep problems in multiple sclerosis.

N Tachibana1, R S Howard, N P Hirsch, D H Miller, I F Moseley, D Fish.   

Abstract

Twenty-eight consecutive patients with multiple sclerosis (MS) were clinically evaluated to determine the presence of sleep-related disorders. There were 12 males and 16 females aged between 22 and 67 with disability ranging between 1.5 and 8.5 on Kurtzke extended disability status score (EDSS). Fifteen patients (54%) reported sleep-related problems. These included difficulties initiating sleep and/or frequent awakenings due to spasms or discomfort in the legs (8 patients), difficulty in initiating or maintaining sleep (3), habitual snoring (4) and nocturia (1). All-night oximetry was performed and the tracings analysed for the number of dips in oxygen saturation (SaO2) or more than 4%. Three patients showed significant sleep-related oxygen desaturation (> 5 dips of > 4% SaO2/h). Subsequent polysomnography performed in 2 of the 3 patients with significant oxygen desaturation confirmed the presence of sleep apnoea. MRI analysis of brain stem regions showed abnormalities in 20/22 cases. The 3 patients showing nocturnal oxygen desaturation had MRI brain stem lesions, but their locations were variable and their general appearance not different from that seen in the 17 without sleep apnoea. Sleep disturbance in MS is common but poorly recognised. It is usually due to leg spasms, pain, immobility, nocturia or medication. It is much less commonly associated with nocturnal respiratory insufficiency.

Entities:  

Mesh:

Year:  1994        PMID: 7851452     DOI: 10.1159/000117070

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  48 in total

Review 1.  Fatigue in multiple sclerosis: mechanisms, evaluation, and treatment.

Authors:  Tiffany J Braley; Ronald D Chervin
Journal:  Sleep       Date:  2010-08       Impact factor: 5.849

2.  Sleepiness, fatigue, and risk of obstructive sleep apnea using the STOP-BANG questionnaire in multiple sclerosis: a pilot study.

Authors:  Robert A Dias; Kimberly A Hardin; Heather Rose; Mark A Agius; Michelle L Apperson; Steven D Brass
Journal:  Sleep Breath       Date:  2012-01-21       Impact factor: 2.816

3.  [Central sleep apnea in multiple sclerosis].

Authors:  A Steffen; J Hagenah; B Wollenberg; N Brüggemann
Journal:  HNO       Date:  2010-04       Impact factor: 1.284

4.  Monitoring my multiple sclerosis: a patient-administered health-assessment scale.

Authors:  Elsie E Gulick; Marie Namey; June Halper
Journal:  Int J MS Care       Date:  2011

5.  Effect of eszopiclone on sleep disturbances and daytime fatigue in multiple sclerosis patients.

Authors:  Hrayr Attarian; Garrick Applebee; Angela Applebee; Bingxia Wang; Melissa Clark; Becky McCormick; Emma Salzman; Catherine Schuman
Journal:  Int J MS Care       Date:  2011

6.  Restless legs syndrome, sleep quality, and perceived cognitive impairment in adults with multiple sclerosis.

Authors:  Katie L J Cederberg; Brenda Jeng; Jeffer E Sasaki; Robert W Motl
Journal:  Mult Scler Relat Disord       Date:  2020-05-18       Impact factor: 4.339

Review 7.  Fatigue in multiple sclerosis: a rational approach to evaluation and treatment.

Authors:  Jay H Rosenberg; Renata Shafor
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

Review 8.  Sleep Abnormalities in Multiple Sclerosis.

Authors:  Giorgos K Sakkas; Christoforos D Giannaki; Christina Karatzaferi; Mauro Manconi
Journal:  Curr Treat Options Neurol       Date:  2019-01-31       Impact factor: 3.598

9.  Low Prevalence of Sleep Disorders in Demyelinating Disease in a Northern Tenerife Population.

Authors:  Montserrat González-Platas; Javier González-Platas; Moises Bermúdez-Hernández; Maria Yaiza Pérez-Martín; Cristina Croissier-Elías; Pedro Javier Pérez-Lorensu
Journal:  J Clin Sleep Med       Date:  2016-06-15       Impact factor: 4.062

10.  Beyond fatigue: Assessing variables associated with sleep problems and use of sleep medications in multiple sclerosis.

Authors:  Alyssa M Bamer; Kurt L Johnson; Dagmar A Amtmann; George H Kraft
Journal:  Clin Epidemiol       Date:  2010-05-01       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.